Aspire Biopharma Holdings, Inc.
ASBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847345
No open-market purchases or sales by Aspire Biopharma Holdings, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $250.9K in total; no superinvestor holds it.
Other share classesASBPW
Q3 2023 vs. Q2 2023
How the institutions holding Aspire Biopharma Holdings, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 14 | 21 | +7 |
| Shares | 1.70M | 1.72M | +18.6K (+1.1%) |
| Value | $17.0M | $18.2M | +$1.14M (+6.7%) |
New holders (10)
Institutions that held Aspire Biopharma Holdings, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vivaldi Asset Management, LLC | 128,449 | $1.39M | 0.08% |
| Shaolin Capital Management LLC | 83,251 | $902.0K | 0.03% |
| Westchester Capital Management, LLC | 36,029 | $419.7K | 0.01% |
| Mizuho Securities USA LLC | 35,000 | $376.3K | 0.01% |
| Toroso Investments, LLC | 11,199 | $130.5K | 0.00% |
| Sea Otter Advisors LLC | 1,452 | $15.7K | 0.01% |
| Quarry LP | 272 | $2.95K | 0.00% |
| UBS Group AG | 60 | $650 | 0.00% |
| Elequin Capital LP | 10 | $108 | 0.00% |
| Tower Research Capital LLC (TRC) | 8 | $87 | 0.00% |
Sold out (3)
Institutions that held Aspire Biopharma Holdings, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Kepos Capital LP | 150,000 | $1.59M |
| Sandia Investment Management LP | 150,000 | $1.56M |
| Clear Street LLC | 49,526 | $516.1K |